VolitionRX (AMEX:VNRX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:10 PM.
Here's what investors need to know about the announcement.
Earnings
VolitionRX missed estimated earnings by 800.0%, reporting an EPS of $-0.14 versus an estimate of $0.02.
Revenue was up $88.68 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 7.1% drop in the share price the next day.
Here's a look at VolitionRX's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.14 | -0.11 | 0.12 | -0.12 |
| EPS Actual | -0.15 | -0.13 | -0.10 | -0.12 |
| Revenue Estimate | 10.00K | 140.00K | 100.00K | 10.00K |
| Revenue Actual | 14.24K | 25.48K | 24.78K | 25.53K |
To track all earnings releases for VolitionRX visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
